Cita APA

Ananthakrishnan, A. N., Sakuraba, A., Barnes, E. L., Pekow, J., Raffals, L., Long, M. D., & Sandler, R. S. (2017). The benefit of combination therapy depends on disease phenotype and duration in Crohn’s disease. Aliment Pharmacol Ther.

Chicago Style Citation

Ananthakrishnan, Ashwin N., Atsushi Sakuraba, Edward L. Barnes, Joel Pekow, Laura Raffals, Millie D. Long, i Robert S. Sandler. "The Benefit of Combination Therapy Depends On Disease Phenotype and Duration in Crohn’s Disease." Aliment Pharmacol Ther 2017.

Cita MLA

Ananthakrishnan, Ashwin N., et al. "The Benefit of Combination Therapy Depends On Disease Phenotype and Duration in Crohn’s Disease." Aliment Pharmacol Ther 2017.